Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71.3M Sell
471,200
-968,700
-67% -$118M 0.02% 611
2025
Q4
$157M Buy
1,439,900
+14,600
+1% +$2.12M 0.04% 342
2025
Q3
$202M Buy
1,425,300
+771,200
+118% +$112M 0.04% 292
2025
Q2
$106M Buy
654,100
+553,900
+553% +$68.8M 0.02% 449
2025
Q1
$10.7M Buy
100,200
+86,600
+637% +$12.1M ﹤0.01% 1356
2024
Q4
$1.68M Buy
13,600
+12,400
+1,033% +$1.75M ﹤0.01% 3035
2024
Q3
$172K Sell
1,200
-138,600
-99% -$19.7M ﹤0.01% 4369
2024
Q2
$22.9M Buy
+139,800
New +$17.4M 0.01% 889
2024
Q1
Sell
-4,500
Closed -$338K 5068
2023
Q4
$338K Buy
+4,500
New +$263K ﹤0.01% 4129

Other funds holding ARM

Barclays's ARM Position: Q1 2026 in Review

Barclays reduced its Arm (ARM) stake by 33% in Q1 2026, selling an estimated $39.3M and leaving 643,726 shares worth $97.4M. The position accounts for 0.02% of the portfolio, ranked #497.

Barclays first reported a position in ARM in Q4 2023 and has held it in 10 quarters since. The position peaked at $106M in Q4 2025. 742 funds tracked by Wall St. Rank hold ARM as of Q1 2026.

  • Barclays held 643,726 shares of Arm worth $97.4M as of Q1 2026.
  • Barclays sold 323,877 Arm shares in Q1 2026, an estimated $39.3M.
  • Arm made up 0.02% of Barclays's portfolio in Q1 2026, its #497 holding.
  • Barclays first reported a position in Arm in Q4 2023 and has held it in 10 quarters since.
  • Barclays's Arm position peaked at $106M in Q4 2025.
  • 742 funds tracked by Wall St. Rank held Arm as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.